In the early stages of tumor development, it inhibits cellular transformation and prevents cancer progression while in later stages, TGF-β plays the oncogenic role and promotes tumor progression by induction of epithelial–mesenchymal transition (EMT), stimulation of angiogenesis, and immunosuppression. The gene discussed is TGFB1; the disease is cancer.